Notice of Renewal of Four Federal Advisory Committees, 36377 [E8-14341]

Download as PDF Federal Register / Vol. 73, No. 124 / Thursday, June 26, 2008 / Notices U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION Notice of Open Public Hearing U.S.-China Economic and Security Review Commission. ACTION: Notice of open public hearing— July 16, 2008, Washington, DC. AGENCY: rfrederick on PROD1PC67 with NOTICES SUMMARY: Notice is hereby given of the following hearing of the U.S.-China Economic and Security Review Commission. Name: Larry Wortzel, Chairman of the U.S.-China Economic and Security Review Commission. The Commission is mandated by Congress to investigate, assess, evaluate and report to Congress annually on ‘‘the national security implications and impact of the bilateral trade and economic relationship between the United States and the People’s Republic of China.’’ Pursuant to this mandate, the Commission will hold a public hearing in Washington, DC on July 16, 2008 to address ‘‘Research and Development and Technological Advances in Key Industries in China.’’ Background This event is the eighth in a series of public hearings the Commission will hold during its 2008 report cycle to collect input from leading academic, industry, and government experts on the impact of the economic and national security implications of the U.S. bilateral trade and economic relationship with China. The July 16 hearing will examine domestic and foreign-funded research and development, Chinese development in key industries, and the changing nature of China’s trade flows. The July 16 hearing will address ‘‘Research and Development and Technological Advances in Key Industries in China’’ and will be cochaired by Commissioners Michael Wessel and Dennis Shea. Information on hearings, as well as transcripts of past Commission hearings, can be obtained from the USCC Web Site https://www.uscc.gov. Copies of the hearing agenda will be made available on the Commission’s Web site https://www.uscc.gov as soon as available. Any interested party may file a written statement by July 16, 2008, by mailing to the contact below. On July 16, the hearing will be held in two sessions, one in the morning and one in the afternoon. There will be a question and answer period between the Commissioners and the witnesses. DATE AND TIME: Wednesday, July 16, 2008, 8:30 a.m. to 4:45 p.m. Eastern VerDate Aug<31>2005 15:05 Jun 25, 2008 Jkt 214001 Daylight Time. A detailed agenda for the hearing will be posted to the Commission’s Web site at https:// www.uscc.gov in the near future. ADDRESSES: The hearing will be held on Capitol Hill in Room 106 Dirksen Senate Office Building located at First Street and Constitution Avenue, NE., Washington, DC 20510. Public seating is limited to about 50 people on a first come, first served basis. Advance reservations are not required. FOR FURTHER INFORMATION CONTACT: Any member of the public wishing further information concerning the hearing should contact Kathy Michels, Associate Director for the U.S.-China Economic and Security Review Commission, 444 North Capitol Street, NW., Suite 602, Washington, DC 20001; phone: 202– 624–1409, or via email at kmichels@uscc.gov. Authority: Congress created the U.S.-China Economic and Security Review Commission in 2000 in the National Defense Authorization Act (Pub. L. 106–398), as amended by Division P of the Consolidated Appropriations Resolution, 2003 (Pub. L. 108–7), as amended by Pub. L. 109–108 (November 22, 2005). Dated: June 23, 2008. Kathleen J. Michels, Associate Director, U.S.-China Economic and Security Review Commission. [FR Doc. E8–14533 Filed 6–25–08; 8:45 am] BILLING CODE 1137–00–P DEPARTMENT OF VETERANS AFFAIRS Notice of Renewal of Four Federal Advisory Committees In compliance with both the Federal Advisory Committee Act (Pub. L. 92– 463) and associated regulations governing the operation of federal advisory committees, the Department of Veterans Affairs (VA) gives notice that four federal advisory committees managed by VA are being renewed for a period of two years each. The name of each committee is provided below, along with a brief description of its principal objective(s). Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee—The Committee’s objectives are to provide expert advice on VA cooperative studies, multi-site clinical research activities, and policies related to conducting and managing these efforts. To accomplish its objectives, the Committee reviews research proposals and makes recommendations to the Director of the Clinical Science PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 36377 Research and Development Service and Chief Research and Development Officer on funding and administration of those proposals. Health Services Research and Development Service Merit Review Board—The objective of the Board is to ensure the high quality and mission relevance of VA’s legislatively mandated research and development program. Board members advise the Director of the Health Services Research and Development Service and the Chief Research and Development Officer on the scientific and technical merit, originality, feasibility, and mission relevance of individual research proposals. They also advise on the adequacy of protection of human and animal subjects and proposed budgets. Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board—The objectives of the Board are to provide expert review of the scientific quality, safety, and mission relevance of investigator-initiated research proposals submitted for VA merit review consideration, and to offer advice on research program priorities and policies. The proposals to be reviewed may address research questions within the general area of biomedical and behavioral research or clinical science research. The Board specifically advises the Directors of the Biomedical Laboratory Research and Development Service and the Clinical Science Research and Development Service and the Chief Research and Development Officer on the administration of VA’s intramural program. Rehabilitation Research and Development Service Scientific Merit Review Board—The objective of the Board is to provide for the fair and equitable selection of the most meritorious research projects for support by VA research funds, and to offer advice on research program priorities and policies. The ultimate objective of the Board is to ensure that the VA Rehabilitation Research and Development program promotes functional independence and improves the quality of life for impaired and disabled veterans. Dated: June 19, 2008. By direction of the Secretary. E. Philip Riggin, Committee Management Officer. [FR Doc. E8–14341 Filed 6–25–08; 8:45 am] BILLING CODE 8320–01–M E:\FR\FM\26JNN1.SGM 26JNN1

Agencies

[Federal Register Volume 73, Number 124 (Thursday, June 26, 2008)]
[Notices]
[Page 36377]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14341]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Notice of Renewal of Four Federal Advisory Committees

    In compliance with both the Federal Advisory Committee Act (Pub. L. 
92-463) and associated regulations governing the operation of federal 
advisory committees, the Department of Veterans Affairs (VA) gives 
notice that four federal advisory committees managed by VA are being 
renewed for a period of two years each. The name of each committee is 
provided below, along with a brief description of its principal 
objective(s).
    Clinical Science Research and Development Service Cooperative 
Studies Scientific Evaluation Committee--The Committee's objectives are 
to provide expert advice on VA cooperative studies, multi-site clinical 
research activities, and policies related to conducting and managing 
these efforts. To accomplish its objectives, the Committee reviews 
research proposals and makes recommendations to the Director of the 
Clinical Science Research and Development Service and Chief Research 
and Development Officer on funding and administration of those 
proposals.
    Health Services Research and Development Service Merit Review 
Board--The objective of the Board is to ensure the high quality and 
mission relevance of VA's legislatively mandated research and 
development program. Board members advise the Director of the Health 
Services Research and Development Service and the Chief Research and 
Development Officer on the scientific and technical merit, originality, 
feasibility, and mission relevance of individual research proposals. 
They also advise on the adequacy of protection of human and animal 
subjects and proposed budgets.
    Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board--The objectives of the Board are to provide expert review of the 
scientific quality, safety, and mission relevance of investigator-
initiated research proposals submitted for VA merit review 
consideration, and to offer advice on research program priorities and 
policies. The proposals to be reviewed may address research questions 
within the general area of biomedical and behavioral research or 
clinical science research. The Board specifically advises the Directors 
of the Biomedical Laboratory Research and Development Service and the 
Clinical Science Research and Development Service and the Chief 
Research and Development Officer on the administration of VA's 
intramural program.
    Rehabilitation Research and Development Service Scientific Merit 
Review Board--The objective of the Board is to provide for the fair and 
equitable selection of the most meritorious research projects for 
support by VA research funds, and to offer advice on research program 
priorities and policies. The ultimate objective of the Board is to 
ensure that the VA Rehabilitation Research and Development program 
promotes functional independence and improves the quality of life for 
impaired and disabled veterans.

    Dated: June 19, 2008.

    By direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. E8-14341 Filed 6-25-08; 8:45 am]
BILLING CODE 8320-01-M